Author:
Foley Robert N.,Parfrey Patrick S.
Reference7 articles.
1. McHorney CA, Ware JE Jr, Raczek AE (1993) The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 31:247–263
2. Fayers PM, Machin D (eds) (2007) Quality of life: the assessment, analysis and interpretation of patient-reported outcomes, 2nd edn. Wiley, Chichester, England
3. Hays RD, Woolley JM (2000) The concept of clinically meaningful difference in health related QoL search. How meaningful is it? Pharmacoeconomics 18:419–423
4. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, Investigators TREAT (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361:2019–2032
5. Marsden PA (2009) Treatment of anemia in chronic kidney disease-strategies based on evidence. N Engl J Med 361:2089–2090